A novel nasal mucosal peptide-modified co-delivery system for ginsenoside Rg1, Rb1, and notoginseng saponin R1 in the amelioration of AD

Authors:

Abstract
The drug delivery for Alzheimer’s disease (AD) faces substantial obstacles owing to the presence of the blood-brain barrier (BBB). This circumstance
Funding Information
  • National Innovation and Entrepreneurship Training Program for Undergraduate (202510315035)
  • National Natural Science Foundation of China (82304729)
  • National Natural Science Foundation of China (82574587)
  • Natural Science Foundation of Jiangsu Province (BK20230457)
  • Scientific Research Foundation of Nanjing University of Chinese Medicine (ZYXYL2024-005)

This publication has 46 references indexed in Scilit: